Recent 8-K filings for CCCC

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 12, 2026 11:05 UTC earnings item 2.02item 7.01item 9.01

  C4 Therapeutics Q1 2026 net loss $25.1M; cash $268.3M; new Roche DAC collaboration

source · CCCC on sec.gov